Multiple lung cancers including squamous cell carcinoma with strong PD-L1 expression and adenocarcinoma with EGFR exon 19 deletion: A case report
Hirokazu Tokuyasu, Mika Horie, Soichiro Ishikawa and 3 more
Respiratory Medicine Case Reports · 2020
doi:10.1016/j.rmcr.2019.100976 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
We herein report a non-smoking 81-year-old man with advanced synchronous multiple primary lung cancers (SMPLC), containing squamous cell carcinoma with strong programmed death-ligand 1 expression in the middle lobe and adenocarcinoma with epidermal growth factor receptor (EGFR) exon 19 deletion in the lower lobe. Programmed death-1 (PD-1) inhibitors were administered as first-line chemotherapy; however, treatment response was poor response. There have been no reported SMPLC cases similar to this. During treatment, his non-smoking status and EGFR deletion might have been the cause of the patient's poor response to first-line PD-1 inhibitor treatment. Keywords: Adenocarcinoma, Epidermal growth factor receptor, Programmed death-ligand 1, Programmed death-1 inhibitors, Squamous cell carcinoma, Synchronous multiple primary lung cancers
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.